RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Cash from investing

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.7B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-379+2.71%
Dec 31, 2023-369+27.93%
Dec 31, 2022-288+13.87%
Dec 31, 2021-253+41.00%
Dec 31, 2020-179-21.27%
Dec 31, 2019-228+126.19%
Dec 31, 2018-101-24.55%
Dec 31, 2017-134-24.00%
Dec 31, 2016-176+35.75%
Dec 31, 2015-129+24.52%
Dec 31, 2014-104-30.62%
Dec 31, 2013-150+29.22%
Dec 31, 2012-116+56.76%
Dec 31, 2010-74

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)